Alivus Life Sciences Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Long Term Debt-Equity Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Current Ratio | 3.65 | 3.78 | 1.90 | 1.00 | 0.77 |
Fixed Assets | 2.34 | 2.63 | 3.13 | 3.02 | 2.87 |
Inventory | 3.59 | 3.86 | 4.12 | 4.07 | 3.78 |
Debtors | 2.90 | 2.92 | 3.28 | 3.00 | 2.83 |
Interest Cover Ratio | 408.28 | 1143.93 | 21.20 | 6.38 | 13.56 |
PBIDTM (%) | 30.06 | 31.06 | 29.71 | 31.40 | 31.48 |
PBITM (%) | 27.72 | 29.11 | 27.92 | 29.63 | 29.57 |
PBDTM (%) | 29.99 | 31.03 | 28.39 | 26.75 | 29.30 |
CPM (%) | 22.97 | 23.55 | 21.51 | 20.42 | 22.28 |
APATM (%) | 20.62 | 21.61 | 19.72 | 18.65 | 20.37 |
ROCE (%) | 27.94 | 29.80 | 42.20 | 96.75 | 185.60 |
RONW (%) | 21.07 | 22.28 | 29.83 | 60.91 | 127.84 |